ASXL2 Regulates Glucose, Lipid, and Skeletal Homeostasis.

Nidhi Rohatgi,Takashi Izawa,Tomohiro Fukunaga,Qun-Tian Wang,Matthew Silva,Michael Gardner,Michael McDaniel,Clay Semenkovich,Wei Zou,Steven Teitelbaum
DOI: https://doi.org/10.1016/j.celrep.2015.05.019
IF: 8.8
2015-01-01
Cell Reports
Abstract:ASXL2 is an ETP family protein that interacts with PPARγ. We find that ASXL2−/− mice are insulin resistant, lipodystrophic, and fail to respond to a high-fat diet. Consistent with genetic variation at the ASXL2 locus and human bone mineral density, ASXL2−/− mice are also severely osteopetrotic because of failed osteoclast differentiation attended by normal bone formation. ASXL2 regulates the osteoclast via two distinct signaling pathways. It induces osteoclast formation in a PPARγ/c-Fos-dependent manner and is required for RANK ligand- and thiazolidinedione-induced bone resorption independent of PGC-1β. ASXL2 also promotes osteoclast mitochondrial biogenesis in a process mediated by PGC-1β but independent of c-Fos. Thus, ASXL2 is a master regulator of skeletal, lipid, and glucose homeostasis.
What problem does this paper attempt to address?